Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Davies C, Pan H, Godwin J, Gray R, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 2012 Dec 4. pii: S0140-6736(12)61963.
PMID: 23219286

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016